nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—GRIN2A—melanoma	0.0202	0.0414	CbGpPWpGaD
Butabarbital—Liver injury—Temozolomide—melanoma	0.02	0.039	CcSEcCtD
Butabarbital—Respiratory failure—Temozolomide—melanoma	0.0171	0.0334	CcSEcCtD
Butabarbital—Depressed level of consciousness—Carmustine—melanoma	0.0168	0.0328	CcSEcCtD
Butabarbital—Depressed level of consciousness—Temozolomide—melanoma	0.0162	0.0317	CcSEcCtD
Butabarbital—GRIA2—Hypothetical Network for Drug Addiction—GRM1—melanoma	0.0147	0.0301	CbGpPWpGaD
Butabarbital—Dermatitis exfoliative—Temozolomide—melanoma	0.0129	0.0252	CcSEcCtD
Butabarbital—GRIA2—Hypothetical Network for Drug Addiction—GRIN2A—melanoma	0.0122	0.0249	CbGpPWpGaD
Butabarbital—Ataxia—Carmustine—melanoma	0.0119	0.0232	CcSEcCtD
Butabarbital—Ataxia—Temozolomide—melanoma	0.0115	0.0224	CcSEcCtD
Butabarbital—Respiratory failure—Docetaxel—melanoma	0.0114	0.0222	CcSEcCtD
Butabarbital—Hepatocellular injury—Docetaxel—melanoma	0.0112	0.0218	CcSEcCtD
Butabarbital—GRIA2—Trafficking of GluR2-containing AMPA receptors—PRKCA—melanoma	0.0111	0.0228	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—POU3F2—melanoma	0.011	0.0226	CbGpPWpGaD
Butabarbital—Hypotension—Vemurafenib—melanoma	0.011	0.0214	CcSEcCtD
Butabarbital—GRIA2—N-cadherin signaling events—CDH2—melanoma	0.0104	0.0213	CbGpPWpGaD
Butabarbital—Constipation—Vemurafenib—melanoma	0.01	0.0196	CcSEcCtD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—GRIN2A—melanoma	0.00998	0.0205	CbGpPWpGaD
Butabarbital—Body temperature increased—Vemurafenib—melanoma	0.00928	0.0181	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—POU3F2—melanoma	0.00898	0.0184	CbGpPWpGaD
Butabarbital—GABRB2—Orphan transporters—ARL2—melanoma	0.0088	0.018	CbGpPWpGaD
Butabarbital—Hallucination—Carmustine—melanoma	0.00869	0.017	CcSEcCtD
Butabarbital—Hypersensitivity—Vemurafenib—melanoma	0.00865	0.0169	CcSEcCtD
Butabarbital—Hallucination—Temozolomide—melanoma	0.0084	0.0164	CcSEcCtD
Butabarbital—GABRG2—Orphan transporters—ARL2—melanoma	0.00804	0.0165	CbGpPWpGaD
Butabarbital—Dizziness—Vemurafenib—melanoma	0.00776	0.0152	CcSEcCtD
Butabarbital—Ataxia—Docetaxel—melanoma	0.00763	0.0149	CcSEcCtD
Butabarbital—Vomiting—Vemurafenib—melanoma	0.00746	0.0146	CcSEcCtD
Butabarbital—Rash—Vemurafenib—melanoma	0.0074	0.0144	CcSEcCtD
Butabarbital—Dermatitis—Vemurafenib—melanoma	0.00739	0.0144	CcSEcCtD
Butabarbital—Headache—Vemurafenib—melanoma	0.00735	0.0144	CcSEcCtD
Butabarbital—Confusional state—Bleomycin—melanoma	0.00717	0.014	CcSEcCtD
Butabarbital—GABRA1—Orphan transporters—ARL2—melanoma	0.00703	0.0144	CbGpPWpGaD
Butabarbital—Agitation—Carmustine—melanoma	0.00699	0.0136	CcSEcCtD
Butabarbital—Nausea—Vemurafenib—melanoma	0.00697	0.0136	CcSEcCtD
Butabarbital—Agitation—Temozolomide—melanoma	0.00675	0.0132	CcSEcCtD
Butabarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—PRKCA—melanoma	0.00673	0.0138	CbGpPWpGaD
Butabarbital—Angioedema—Temozolomide—melanoma	0.00672	0.0131	CcSEcCtD
Butabarbital—Hypotension—Bleomycin—melanoma	0.00664	0.013	CcSEcCtD
Butabarbital—Anxiety—Carmustine—melanoma	0.00645	0.0126	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—MAP2—melanoma	0.00633	0.013	CbGpPWpGaD
Butabarbital—Confusional state—Carmustine—melanoma	0.00626	0.0122	CcSEcCtD
Butabarbital—GRIA2—Hypothetical Network for Drug Addiction—MAP2K2—melanoma	0.00625	0.0128	CbGpPWpGaD
Butabarbital—Anxiety—Temozolomide—melanoma	0.00624	0.0122	CcSEcCtD
Butabarbital—Confusional state—Temozolomide—melanoma	0.00605	0.0118	CcSEcCtD
Butabarbital—GRIK2—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00601	0.0123	CbGpPWpGaD
Butabarbital—Feeling abnormal—Bleomycin—melanoma	0.00586	0.0114	CcSEcCtD
Butabarbital—Hypotension—Carmustine—melanoma	0.0058	0.0113	CcSEcCtD
Butabarbital—Body temperature increased—Bleomycin—melanoma	0.00562	0.011	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—POU3F2—melanoma	0.00556	0.0114	CbGpPWpGaD
Butabarbital—Somnolence—Carmustine—melanoma	0.00552	0.0108	CcSEcCtD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00547	0.0112	CbGpPWpGaD
Butabarbital—Feeling abnormal—Dactinomycin—melanoma	0.00547	0.0107	CcSEcCtD
Butabarbital—GRIA2—N-cadherin signaling events—RAC1—melanoma	0.00539	0.0111	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—TP73—melanoma	0.00538	0.011	CbGpPWpGaD
Butabarbital—Somnolence—Temozolomide—melanoma	0.00533	0.0104	CcSEcCtD
Butabarbital—Constipation—Carmustine—melanoma	0.00531	0.0104	CcSEcCtD
Butabarbital—Body temperature increased—Dactinomycin—melanoma	0.00524	0.0102	CcSEcCtD
Butabarbital—Hypersensitivity—Bleomycin—melanoma	0.00524	0.0102	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—MAP2—melanoma	0.00516	0.0106	CbGpPWpGaD
Butabarbital—Constipation—Temozolomide—melanoma	0.00513	0.01	CcSEcCtD
Butabarbital—Feeling abnormal—Carmustine—melanoma	0.00511	0.00998	CcSEcCtD
Butabarbital—Feeling abnormal—Temozolomide—melanoma	0.00494	0.00965	CcSEcCtD
Butabarbital—Body temperature increased—Carmustine—melanoma	0.00491	0.00958	CcSEcCtD
Butabarbital—Hypersensitivity—Dactinomycin—melanoma	0.00489	0.00954	CcSEcCtD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.00489	0.01	CbGpPWpGaD
Butabarbital—Body temperature increased—Temozolomide—melanoma	0.00474	0.00926	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—SLC6A11—melanoma	0.00461	0.00945	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—SLC6A11—melanoma	0.0046	0.00943	CbGpPWpGaD
Butabarbital—Hypersensitivity—Carmustine—melanoma	0.00457	0.00893	CcSEcCtD
Butabarbital—Vomiting—Bleomycin—melanoma	0.00452	0.00883	CcSEcCtD
Butabarbital—Rash—Bleomycin—melanoma	0.00448	0.00875	CcSEcCtD
Butabarbital—Dermatitis—Bleomycin—melanoma	0.00448	0.00874	CcSEcCtD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00446	0.00914	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.00444	0.00911	CbGpPWpGaD
Butabarbital—GRIA2—Hypothetical Network for Drug Addiction—MAP2K1—melanoma	0.00443	0.00908	CbGpPWpGaD
Butabarbital—Hypersensitivity—Temozolomide—melanoma	0.00442	0.00863	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TP73—melanoma	0.00438	0.00899	CbGpPWpGaD
Butabarbital—Syncope—Docetaxel—melanoma	0.00438	0.00856	CcSEcCtD
Butabarbital—Loss of consciousness—Docetaxel—melanoma	0.0043	0.00839	CcSEcCtD
Butabarbital—Nausea—Bleomycin—melanoma	0.00422	0.00825	CcSEcCtD
Butabarbital—Vomiting—Dactinomycin—melanoma	0.00422	0.00823	CcSEcCtD
Butabarbital—CHRNA7—Neuronal System—SLC6A11—melanoma	0.00419	0.00859	CbGpPWpGaD
Butabarbital—Rash—Dactinomycin—melanoma	0.00418	0.00816	CcSEcCtD
Butabarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—melanoma	0.00415	0.00851	CbGpPWpGaD
Butabarbital—Dizziness—Carmustine—melanoma	0.0041	0.00801	CcSEcCtD
Butabarbital—Confusional state—Docetaxel—melanoma	0.00402	0.00785	CcSEcCtD
Butabarbital—GRIA2—BDNF signaling pathway—BCL2L11—melanoma	0.00401	0.00822	CbGpPWpGaD
Butabarbital—Dizziness—Temozolomide—melanoma	0.00397	0.00774	CcSEcCtD
Butabarbital—Vomiting—Carmustine—melanoma	0.00395	0.0077	CcSEcCtD
Butabarbital—Nausea—Dactinomycin—melanoma	0.00394	0.00769	CcSEcCtD
Butabarbital—Shock—Docetaxel—melanoma	0.00392	0.00766	CcSEcCtD
Butabarbital—Rash—Carmustine—melanoma	0.00391	0.00764	CcSEcCtD
Butabarbital—Dermatitis—Carmustine—melanoma	0.00391	0.00763	CcSEcCtD
Butabarbital—Headache—Carmustine—melanoma	0.00389	0.00759	CcSEcCtD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—melanoma	0.00386	0.00791	CbGpPWpGaD
Butabarbital—Vomiting—Temozolomide—melanoma	0.00381	0.00744	CcSEcCtD
Butabarbital—Rash—Temozolomide—melanoma	0.00378	0.00738	CcSEcCtD
Butabarbital—Dermatitis—Temozolomide—melanoma	0.00378	0.00738	CcSEcCtD
Butabarbital—Headache—Temozolomide—melanoma	0.00376	0.00734	CcSEcCtD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.00374	0.00766	CbGpPWpGaD
Butabarbital—Hypotension—Docetaxel—melanoma	0.00373	0.00728	CcSEcCtD
Butabarbital—Nausea—Carmustine—melanoma	0.00369	0.0072	CcSEcCtD
Butabarbital—GRIK2—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00367	0.00753	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.00362	0.00743	CbGpPWpGaD
Butabarbital—Nausea—Temozolomide—melanoma	0.00356	0.00696	CcSEcCtD
Butabarbital—Somnolence—Docetaxel—melanoma	0.00355	0.00692	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—SLC6A11—melanoma	0.00352	0.00722	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00345	0.00708	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CDH2—melanoma	0.00343	0.00704	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—SLC6A11—melanoma	0.00342	0.007	CbGpPWpGaD
Butabarbital—Constipation—Docetaxel—melanoma	0.00341	0.00666	CcSEcCtD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00334	0.00685	CbGpPWpGaD
Butabarbital—Feeling abnormal—Docetaxel—melanoma	0.00329	0.00642	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—MAP2—melanoma	0.00319	0.00655	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00316	0.00648	CbGpPWpGaD
Butabarbital—Body temperature increased—Docetaxel—melanoma	0.00315	0.00616	CcSEcCtD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCB5—melanoma	0.0031	0.00635	CbGpPWpGaD
Butabarbital—GRIA2—N-cadherin signaling events—CTNNB1—melanoma	0.0031	0.00635	CbGpPWpGaD
Butabarbital—Hypersensitivity—Docetaxel—melanoma	0.00294	0.00574	CcSEcCtD
Butabarbital—GRIA2—BDNF signaling pathway—PTK2B—melanoma	0.00292	0.00599	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCB5—melanoma	0.00283	0.00581	CbGpPWpGaD
Butabarbital—GRIA2—Hypothetical Network for Drug Addiction—MAPK3—melanoma	0.00283	0.00581	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—GRIN2A—melanoma	0.00281	0.00577	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00281	0.00576	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.00281	0.00575	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00276	0.00566	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00272	0.00558	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TP73—melanoma	0.00271	0.00557	CbGpPWpGaD
Butabarbital—GRIA2—Hypothetical Network for Drug Addiction—MAPK1—melanoma	0.00269	0.00553	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—SLC6A11—melanoma	0.00265	0.00542	CbGpPWpGaD
Butabarbital—Dizziness—Docetaxel—melanoma	0.00264	0.00515	CcSEcCtD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.00257	0.00526	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.00257	0.00526	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—GRIN2A—melanoma	0.00256	0.00525	CbGpPWpGaD
Butabarbital—Vomiting—Docetaxel—melanoma	0.00254	0.00495	CcSEcCtD
Butabarbital—Rash—Docetaxel—melanoma	0.00252	0.00491	CcSEcCtD
Butabarbital—Dermatitis—Docetaxel—melanoma	0.00251	0.00491	CcSEcCtD
Butabarbital—Headache—Docetaxel—melanoma	0.0025	0.00488	CcSEcCtD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCB5—melanoma	0.00248	0.00508	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—NGFR—melanoma	0.00244	0.005	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—SLC6A11—melanoma	0.00242	0.00496	CbGpPWpGaD
Butabarbital—Nausea—Docetaxel—melanoma	0.00237	0.00463	CcSEcCtD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.00233	0.00479	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—melanoma	0.00226	0.00463	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.00224	0.0046	CbGpPWpGaD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—melanoma	0.00221	0.00453	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—GRIN2A—melanoma	0.00215	0.00441	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ARL2—melanoma	0.00215	0.0044	CbGpPWpGaD
Butabarbital—GRIA2—N-cadherin signaling events—PIK3CA—melanoma	0.00213	0.00436	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—SLC6A11—melanoma	0.00212	0.00434	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00211	0.00433	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—GRIN2A—melanoma	0.00209	0.00428	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ARL2—melanoma	0.00196	0.00403	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.00196	0.00402	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—PRKCA—melanoma	0.00193	0.00396	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00193	0.00396	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—melanoma	0.0019	0.0039	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.0019	0.0039	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.00189	0.00387	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—SPP1—melanoma	0.00188	0.00386	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAP2K2—melanoma	0.00188	0.00385	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—melanoma	0.00184	0.00378	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—RAC1—melanoma	0.00178	0.00365	CbGpPWpGaD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—melanoma	0.00177	0.00364	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—PRKCA—melanoma	0.00176	0.0036	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.00172	0.00352	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ARL2—melanoma	0.00172	0.00352	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00169	0.00346	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00163	0.00334	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—GRIN2A—melanoma	0.00162	0.00331	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.00158	0.00325	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00157	0.00321	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—melanoma	0.00155	0.00318	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—APC—melanoma	0.0015	0.00308	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00149	0.00305	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—GRIN2A—melanoma	0.00148	0.00303	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—PRKCA—melanoma	0.00148	0.00303	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—PRKCA—melanoma	0.00148	0.00302	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.00147	0.00302	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.00144	0.00296	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.00144	0.00295	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00143	0.00294	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—PRKCA—melanoma	0.00143	0.00293	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00142	0.00292	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—BRAF—melanoma	0.00142	0.00291	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.0014	0.00287	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.00135	0.00276	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—PRKCA—melanoma	0.00134	0.00276	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAP2K1—melanoma	0.00133	0.00273	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.0013	0.00267	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.0013	0.00267	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—BRAF—melanoma	0.00129	0.00265	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—GRIN2A—melanoma	0.00129	0.00265	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00125	0.00257	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—melanoma	0.00123	0.00253	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.00121	0.00248	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—MDM2—melanoma	0.00119	0.00244	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—melanoma	0.00118	0.00242	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.00118	0.00242	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.00117	0.00241	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL10—melanoma	0.00114	0.00234	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.00114	0.00234	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00114	0.00233	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—PRKCA—melanoma	0.00113	0.00232	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—PRKCA—melanoma	0.00111	0.00227	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—NFKB1—melanoma	0.00111	0.00227	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—PRKCA—melanoma	0.0011	0.00225	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—BRAF—melanoma	0.00109	0.00223	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—BRAF—melanoma	0.00109	0.00223	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.00109	0.00223	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—melanoma	0.00108	0.00222	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.00108	0.00222	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CASP3—melanoma	0.00106	0.00217	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—BRAF—melanoma	0.00105	0.00216	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CTNNB1—melanoma	0.00102	0.00209	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—PRKCA—melanoma	0.00101	0.00208	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—melanoma	0.00101	0.00206	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—melanoma	0.001	0.00206	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.000993	0.00204	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—NFKB1—melanoma	0.00099	0.00203	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—BRAF—melanoma	0.00099	0.00203	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000984	0.00202	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—melanoma	0.000964	0.00198	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000961	0.00197	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000929	0.0019	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—MDM2—melanoma	0.000912	0.00187	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—MDM2—melanoma	0.00091	0.00187	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.000909	0.00186	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000901	0.00185	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—STAT3—melanoma	0.00089	0.00182	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—PRKCA—melanoma	0.000886	0.00182	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—melanoma	0.000883	0.00181	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000869	0.00178	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.000868	0.00178	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—melanoma	0.00086	0.00176	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAPK3—melanoma	0.00085	0.00174	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—PRKCA—melanoma	0.000849	0.00174	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—BRAF—melanoma	0.000832	0.00171	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.000832	0.00171	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—MDM2—melanoma	0.00083	0.0017	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000827	0.0017	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000818	0.00168	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—BRAF—melanoma	0.000816	0.00167	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—MAPK1—melanoma	0.000813	0.00167	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAPK1—melanoma	0.000809	0.00166	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—BRAF—melanoma	0.000807	0.00165	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000803	0.00165	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.00079	0.00162	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—PRKCA—melanoma	0.000777	0.00159	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—BRAF—melanoma	0.000746	0.00153	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—melanoma	0.00074	0.00152	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.000727	0.00149	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—melanoma	0.000701	0.00144	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—MDM2—melanoma	0.000697	0.00143	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—melanoma	0.000694	0.00142	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—MDM2—melanoma	0.000684	0.0014	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—PRKCA—melanoma	0.000679	0.00139	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—MDM2—melanoma	0.000676	0.00139	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000664	0.00136	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—HRAS—melanoma	0.000653	0.00134	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—BRAF—melanoma	0.000652	0.00134	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000651	0.00133	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—HRAS—melanoma	0.00065	0.00133	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000644	0.00132	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—MDM2—melanoma	0.000625	0.00128	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—BRAF—melanoma	0.000625	0.00128	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—MAPK1—melanoma	0.000623	0.00128	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000623	0.00128	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—melanoma	0.000622	0.00128	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000622	0.00127	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—melanoma	0.000603	0.00124	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000597	0.00122	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000595	0.00122	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—melanoma	0.000594	0.00122	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000575	0.00118	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—AKT1—melanoma	0.000574	0.00118	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—BRAF—melanoma	0.000572	0.00117	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000568	0.00117	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—MAPK1—melanoma	0.000567	0.00116	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—melanoma	0.000566	0.00116	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000558	0.00114	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—MDM2—melanoma	0.000546	0.00112	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—MDM2—melanoma	0.000524	0.00107	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.00052	0.00107	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000506	0.00104	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—HRAS—melanoma	0.0005	0.00103	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—BRAF—melanoma	0.0005	0.00102	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—HRAS—melanoma	0.000499	0.00102	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000499	0.00102	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000497	0.00102	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—melanoma	0.000496	0.00102	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—melanoma	0.000484	0.000993	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—MDM2—melanoma	0.000479	0.000982	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—MAPK1—melanoma	0.000477	0.000977	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—MAPK1—melanoma	0.000467	0.000958	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—MAPK1—melanoma	0.000462	0.000948	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000456	0.000936	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—HRAS—melanoma	0.000455	0.000933	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	0.000454	0.00093	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	0.000434	0.00089	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	0.000427	0.000876	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—MDM2—melanoma	0.000419	0.000858	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000399	0.000818	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000397	0.000813	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—HRAS—melanoma	0.000383	0.000785	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—HRAS—melanoma	0.000375	0.000769	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	0.000374	0.000766	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—HRAS—melanoma	0.000371	0.000761	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—MAPK1—melanoma	0.000358	0.000734	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	0.00035	0.000718	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	0.000343	0.000703	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—MAPK1—melanoma	0.000327	0.000671	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	0.00031	0.000636	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	0.0003	0.000615	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—HRAS—melanoma	0.000287	0.000589	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—MAPK1—melanoma	0.000286	0.000587	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	0.000284	0.000582	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—HRAS—melanoma	0.000263	0.000539	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	0.000248	0.000509	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—HRAS—melanoma	0.00023	0.000471	CbGpPWpGaD
